GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (SHSE:600332) » Definitions » Days Payable

Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) Days Payable : 78.72 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Days Payable?

Guangzhou Baiyunshan Pharmaceutical Holdings Co's average Accounts Payable for the three months ended in Mar. 2024 was ¥15,414 Mil. Guangzhou Baiyunshan Pharmaceutical Holdings Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥17,867 Mil. Hence, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Days Payable for the three months ended in Mar. 2024 was 78.72.

The historical rank and industry rank for Guangzhou Baiyunshan Pharmaceutical Holdings Co's Days Payable or its related term are showing as below:

SHSE:600332' s Days Payable Range Over the Past 10 Years
Min: 60.41   Med: 87.02   Max: 99.17
Current: 89.25

During the past 13 years, Guangzhou Baiyunshan Pharmaceutical Holdings Co's highest Days Payable was 99.17. The lowest was 60.41. And the median was 87.02.

SHSE:600332's Days Payable is ranked better than
50.41% of 974 companies
in the Drug Manufacturers industry
Industry Median: 88.68 vs SHSE:600332: 89.25

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Days Payable declined from Mar. 2023 (81.13) to Mar. 2024 (78.72). It may suggest that Guangzhou Baiyunshan Pharmaceutical Holdings Co accelerated paying its suppliers.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Days Payable Historical Data

The historical data trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Days Payable Chart

Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 88.78 99.17 94.53 94.23 91.20

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81.13 89.59 95.62 98.05 78.72

Competitive Comparison of Guangzhou Baiyunshan Pharmaceutical Holdings Co's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Baiyunshan Pharmaceutical Holdings Co's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Guangzhou Baiyunshan Pharmaceutical Holdings Co's Days Payable falls into.



Guangzhou Baiyunshan Pharmaceutical Holdings Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (14960.831 + 15685.868) / 2 ) / 61328.11*365
=15323.3495 / 61328.11*365
=91.20

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (15685.868 + 15142.204) / 2 ) / 17867.263*365 / 4
=15414.036 / 17867.263*365 / 4
=78.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Days Payable Related Terms

Thank you for viewing the detailed overview of Guangzhou Baiyunshan Pharmaceutical Holdings Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) Business Description

Traded in Other Exchanges
Address
89 Queensway, Room 2005, 20th Floor, Tower Two, Lippo Center, Hong Kong, HKG
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the Chinese healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its segment includes Great Southern TCM; Great Health; Great Commerce and others. The company generates maximum revenue from the Great Commerce segment.

Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) Headlines

No Headlines